Works contract classification governs composite layout-development contracts where VAT-paid goods are transferred alongside construction and infrastru...
Specified income tax exemption for pollution control body remains conditional on non-commercial activity, unchanged income character, and return filin...
Jurisdictional facts in certificate-of-origin discrepancies can support customs show-cause proceedings, leaving factual explanations for departmental ...
The Applicant provides research and development services related to the agro-chemical sector, specifically testing and analysis of insecticide-infused mosquito nets. The Applicant sought clarification on the applicability of Notification No. 04/2019-Integrated Tax, which exempts certain research and development services in the pharmaceutical sector from GST. The Authority held that the Notification applies only to services related to the pharmaceutical sector and does not cover the agro-chemical sector. The Applicant's services do not fall within the scope of the Notification as they involve quality studies of insecticide-infused mosquito nets, which are distinct from research and development services aimed at producing new drugs or evaluating drug safety in the pharmaceutical sector. Consequently, the Applicant's services remain taxable u/s 13(3) of the IGST Act, 2017, and the Notification is not applicable.
The Applicant provides research and development services related to the agro-chemical sector, specifically testing and analysis of insecticide-infused mosquito nets. The Applicant sought clarification on the applicability of Notification No. 04/2019-Integrated Tax, which exempts certain research and development services in the pharmaceutical sector from GST. The Authority held that the Notification applies only to services related to the pharmaceutical sector and does not cover the agro-chemical sector. The Applicant's services do not fall within the scope of the Notification as they involve quality studies of insecticide-infused mosquito nets, which are distinct from research and development services aimed at producing new drugs or evaluating drug safety in the pharmaceutical sector. Consequently, the Applicant's services remain taxable u/s 13(3) of the IGST Act, 2017, and the Notification is not applicable.
Note: It is a system-generated summary and is for quick reference only.